SCHEMBL10049211

SCHEMBL10049211

O=C(CNc1c(-c2ccc(F)cc2)nc2cnccn12)N1CCN(CCC2CCCCC2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.54
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 4/20 0.54
HPGD P15428 3/20 0.54
CASP1 P29466 3/20 0.54
CASP7 P55210 3/20 0.54
HSD17B10 Q99714 2/20 0.54
ALOX15 P16050 1/20 0.54
ATM Q13315 5/20 0.47
TLR9 Q9NR96 4/20 0.47
ALOX5 P09917 2/20 0.46
MAPT P10636 2/20 0.44
GFER P55789 1/20 0.44
PRKD3 O94806 1/20 0.44
MAP4K4 O95819 1/20 0.44
PRKCG P05129 1/20 0.44
FGFR1 P11362 1/20 0.44
MAPK1 P28482 1/20 0.44
FLT4 P35916 1/20 0.44
FRK P42685 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10048714 0.92 ATM (0.46) GAAKDM4EALDH1A1HPGDCASP1
SCHEMBL10048719 0.91 ALOX5 (0.53) GAAKDM4EALDH1A1HPGDCASP1
SCHEMBL14963824 0.90 ATM (0.46) GAAKDM4EALDH1A1HPGDCASP1
SCHEMBL10049165 0.90 GAA (0.49) GAAKDM4EALDH1A1HPGDCASP1
SCHEMBL10048889 0.89 ATM (0.45) GAAKDM4EALDH1A1HPGDCASP1
SCHEMBL14963686 0.87 ATM (0.41) GAAKDM4EALDH1A1HPGDCASP1
SCHEMBL14963798 0.86 GAA (0.58) GAAKDM4EALDH1A1HPGDCASP1
SCHEMBL10048755 0.85 ATM (0.49) GAAKDM4EALDH1A1HPGDCASP1
SCHEMBL14963793 0.84 GAA (0.66) GAAKDM4EALDH1A1HPGDCASP1
SCHEMBL10049214 0.84 GAA (0.58) GAAKDM4EALDH1A1HPGDCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130131073-A1 FUSED-IMIDAZOYL COMPOUNDS USEFUL AS ANTIMICROBIAL AGENTS MERCK SHARP & DOHME CORP. 2013-05-23 US disclosed
US-20130131073-A1 FUSED-IMIDAZOYL COMPOUNDS USEFUL AS ANTIMICROBIAL AGENTS MERCK SHARP & DOHME CORP. 2013-05-23 US disclosed
WO-2012018665-A1 FUSED-IMIDAZOYL COMPOUNDS USEFUL AS ANTIMICROBIAL AGENTS SCHERING CORPORATION (US) 2012-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131073-A1 FUSED-IMIDAZOYL COMPOUNDS USEFUL AS ANTIMICROBIAL AGENTS MRPL21, ARG1, RPS4Y1 GAA 1859/4885KDM4E 4027/4885ALDH1A1 1069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.